Publications by authors named "A Vellodi"

Claim this Profile
T
Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease.
Aimee Donald, Cecilia Kämpe Björkvall, Ashok Vellodi, , Timothy M Cox

Orphanet J Rare Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The definition of neuronopathic Gaucher disease.
Raphael Schiffmann, Jeff Sevigny, Arndt Rolfs, Elin Haf Davies, Ozlem Goker-Alpan, Ashok Vellodi

J Inherit Metab Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of impact of anti-idursulfase antibodies during long-term idursulfase enzyme replacement therapy in mucopolysaccharidosis II patients.
R Giugliani, P Harmatz, S A Jones, N J Mendelsohn, A Vellodi

Mol Genet Metab Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
Amal El-Beshlawy, Anna Tylki-Szymanska, Ashok Vellodi, Nadia Belmatoug, Gregory A Grabowski

Mol Genet Metab· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation.
A S Kunin-Batson, E G Shapiro, K D Rudser, C A Lavery, K J Bjoraker, A Vellodi

JIMD Rep· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis